Autoradiographic characterization of [3H]cGMP binding sites in the rat brain

Brain Research

Volumn 763, Issue 1, 1997, Pages 1-13

  Bonkale, W L ^a   Cowburn, R F ^a   Winblad, B ^a   Fastbom, J ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Autoradiography; Cyclic adenosine monophosphate; Cyclic guanosine monophosphate; Phosphodiesterase; Protein kinase; Rat brain

Indexed keywords

8 BROMO CYCLIC GMP; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; ISOBUTYLMETHYLXANTHINE; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; CONTROLLED STUDY; INTERPEDUNCULAR NUCLEUS; MALE; NONHUMAN; PH; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SUBSTANTIA NIGRA; ANIMAL; BRAIN; DOSE RESPONSE; METABOLISM; SPRAGUE DAWLEY RAT;

1-METHYL-3-ISOBUTYLXANTHINE; ANIMALS; AUTORADIOGRAPHY; BINDING SITES; BRAIN; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030612575     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00391-0     Document Type: Article

References (41)

1. S.W. Barger, R.R. Fiscus, P. Ruth, F. Hofmann, M.P. Mattson, Role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of β-amyloid precursor, J. Neurochem. 64 (1995) 2087-2096.
2. J.A. Beavo, Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms, Physiol. Rev. 75 (1995) 725-748.
3. 3H]cGMP binding sites in the rat brain, J. Chem. Neuroanat. 10 (1996) 287-293.
4. R.A.J. Challis, A.L. Willcocks, B. Mulloy, B.V.L. Potter, S.R. Nahorski, Characterization of inositol 1,4,5-triphosphate-and 1,3,4,5-tetrakisphosphate-binding sites in rat cerebellum, Biochem. J. 274 (1991) 861-867.
5. H. Charbonneau, N. Beier, K.A. Walsh, J.A. Beavo, Identification of a conserved domain among cyclic nucleotide phosphodiesterases from diverse species, Proc. Natl. Acad. Sci. USA 83 (1986) 9308-9312.
6. M. Chasin, D.N. Harris, Inhibitors and activators of cyclic nucleotide phosphodiesterases, Adv. Cyclic Nucleotide Res. 7 (1976) 225-264.
7. J.D. Corbin, S.O. Døskeland, Studies of two different intrachain cGMP-binding sites of cGMP-dependent protein kinase, J. Biol. Chem. 258 (1983) 11391-11397.
8. J.D. Corbin, D. Øgreid, J.P. Miller, R.H. Suva, B. Jastorff, S.O. Døskeland, Studies of cGMP analog specificity and function of the two intrasubunit binding sites of cGMP-dependent protein kinase, J. Biol. Chem. 261 (1986) 1208-1214.
9. S.O. DØskeland, O.K. Vintermyr, J.D. Corbin, D. Øgreid, Studies on the interactions between the cyclic nucleotide-binding sites of cGMP-dependent protein kinase, J. Biol. Chem. 262 (1987) 3534-3540.
10. C. Erneux, F. Miot, J.-M. Boeynaems, J.E. Dumont, Paradoxical stimulation by 1-methyl-3-isobutylxanthine of rat liver cyclic AMP phosphodiesterase activity, FEBS Lett. 142 (1982) 251-254.
11. S.H. Francis, T.M. Lincoln, J.D. Corbin, Characterization of a novel cGMP binding protein from rat lung, J. Biol. Chem. 255 (1980) 620-626.
12. S.H. Francis, J.D. Corbin, Progress in understanding the mechanism and function of cyclic GMP-dependent protein kinase, Adv. Pharmacol. 26 (1994) 115-170.
13. + channels and suppression of neuronal activity by secreted β-amyloid-precursor protein, Nature 379 (1996) 74-78.
14. D.M. Gamm, S.H. Francis, T.P. Angelotti, J.D. Corbin, M.D. Uhler, The type II isoform of cGMP-dependent protein kinase is dimeric and possesses regulatory and catalytic properties distinct from the type I isoforms, J. Biol. Chem. 270 (1995) 27380-27388.
15. W.A. Geary, A.W. Toga, G.F. Wooten, Quantitative film autoradiography for tritium: methodological considerations, Brain Res. 337 (1985) 99-108.
16. G.N. Gill, K.E. Holdy, G.M. Walton, C.B. Kanstein, Purification and characterization of 3′:5′-cyclic GMP-dependent protein kinase, Proc. Natl. Acad. Sci. USA 73 (1976) 3918-3922.
17. L.H. Greenberg, E. Troyer, J.A. Ferrendelli, B. Weiss, Enzymatic regulation of the concentration of cyclic GMP in mouse brain, Neuropharmacology 17 (1978) 737-745.
18. 3H]cyclic AMP: implications for organization of second messenger systems, Neuroscience 29 (1989) 695-714.
19. S. Kakiuchi, R. Yamazaki, Y. Teshima, K. Uenishi, E. Miyamoto, Multiple cyclic nucleotide phosphodiesterase activities from rat tissues and occurrence of a calcium-plus-magnesium-ion-dependent phosphodiesterase and its protein activator, Biochem. J. 146 (1975) 109-120.
20. T.M. Lincoln, T.L. Cornwell, Intracellular cyclic GMP receptor proteins, FASEB J. 7 (1993) 328-338.
21. S.M. Lohmann, U. Walter, P.E. Miller, P. Greengard, P. De Camilli, Immunocytochemical localization of cyclic GMP-dependent protein kinase in mammalian brain, Proc. Natl. Acad. Sci. USA 78 (1981) 653-657.
22. V.C. Manganiello, T. Murata, M. Taira, P. Belfrage, E. Degerman, Perspectives in biochemistry and biophysics: diversity in cyclic nucleotide phosphodiesterase isoenzyme families, Arch. Biochem. Biophys. 322 (1995) 1-13.
23. R.W. McCune, G.N. Gill, Positive cooperativity in guanosine 3′:5′-monophosphate binding to guanosine 3′:5′-monophosphate-dependent protein kinase, J. Biol. Chem. 254 (1979) 5083-5091.
24. F. Miot, P.J.M. Van Haastert, C. Erneux, Specificity of cGMP binding to a purified cGMP-stimulated phosphodiesterase from bovine adrenal tissue, Eur. J. Biochem. 149 (1985) 59-65.
25. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, Academic Press, Sydney, 1982.
26. S.R. Rannels, J.D. Corbin, Two different intrachain cAMP binding sites of cAMP-dependent protein kinases, J. Biol. Chem. 255 (1980) 7085-7088.
27. D.R. Repaske, J.G. Corbin, M. Conti, M.F. Goy, A cGMP-stimulated cyclic nucleotide phosphodiesterase gene is highly expressed in the limbic system of the rat brain, Neuroscience 56 (1993) 673-686.
28. C.S. Rubin, R. Rangel-Aldao, D. Sarkar, J. Erlichman, N. Fleischer, Characterization and comparison of membrane-associated and cytosolic cAMP-dependent protein kinases, J. Biol. Chem. 254 (1980) 3797-3805.
29. D.J. Schlichter, J.A. Detre, D.A. Aswad, B. Chehrazi, P. Greengard, Localization of cyclic GMP-dependent protein kinase and substrate in mammalian cerebellum, Proc. Natl. Acad. Sci. USA 77 (1980) 5537-5541.
30. J.D. Scott, Cyclic nucleotide-dependent protein kinases, Pharmacol. Ther. 50 (1991) 123-145.
31. W.K. Sonnenburg, P.J. Mullaney, J.A. Beavo, Molecular cloning of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase cDNA, J. Biol. Chem. 266 (1991) 17655-17661.
32. W.K. Sonnenburg, J.A. Beavo, Cyclic GMP and regulation of nucleotide hydrolysis, Adv. Pharmacol. 26 (1992) 87-113.
33. S.D. Stroop, H. Charbonneau, J.A. Beavo, Direct photolabeling of the cGMP-stimulated cyclic nucleotide phosphodiesterase, J. Biol. Chem. 264 (1989) 13718-13725.
34. S.D. Stroop, J.A. Beavo, Structure and function studies of the cGMP-stimulated phosphodiesterase, J. Biol. Chem. 266 (1991) 23802-23809.
35. M.K. Thomas, S.H. Francis, J.D. Corbin, Characterization of a purified bovine lung cGMP-binding phosphodiesterase, J. Biol. Chem. 265 (1990) 14964-14970.
36. M.T. Thomas, S.H. Francis, S.J. Beebe, T.W. Gettys, J.D. Corbin, Partial mapping of cyclic nucleotide sites and studies of regulatory mechanisms of phosphodiesterases using cyclic nucleotide analogues, Adv. Second Messenger Phosph. Res. 25 (1992) 45-53.
37. H. Wada, J.C. Osborne Jr., V.C. Manganiello, Effects of pH on allosteric and catalytic properties of the guanosine cyclic 3′,5′-phosphate stimulated cyclic nucleotide phosphodiesterase from calf liver, Biochemistry 26 (1987) 6565-6570.
38. B. Weiss, R. Levin, Mechanism for selectively inhibiting the activation of cyclic nucleotide phosphodiesterase and adenylate cyclase by antipsychotic agents, Adv. Cyclic Nucleotide Res. 9 (1978) 285-303.
39. M.E. Whalin, S.J. Strada, W.J. Thompson, Purification and partial characterization of membrane-associated type II (cGMP-activatable) cyclic nucleotide phosphodiesterase from rabbit brain, Biochim. Biophys. Acta 972 (1988) 79-94.
40. T. Yamamoto, S. Yamamoto, J.C. Osborne, V.C. Manganiello Jr., M. Vaughan, Complex effects of inhibitors on cyclic GMP-stimulated cyclic nucleotide phosphodiesterase, J. Biol. Chem. 258 (1983) 14173-14177.
41. M. Zhuo, Y. Hu, C. Schultz, E.R. Kandel, R.D. Hawkins, Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation, Nature 368 (1994) 635-639.